Telemedicine for Contraceptive Counselling- An Open Randomized Controlled Trial
Tele-prev
Tele-health for Contraceptive Counselling - a Randomized Controlled Trial of Contraceptive Counselling Via Tele-health Compared to Standard Routine on the Effects of Choice and Uptake of LARC
1 other identifier
interventional
772
0 countries
N/A
Brief Summary
Protocol Summary: Sweden has high unintended pregnancy rates, increasing unmet contraceptive needs, and the highest repeat abortion rate in the European Union. Effective contraceptive counseling can improve satisfaction, empower correct use, and increase uptake of long-acting reversible contraceptives (LARC), potentially reducing unintended pregnancies. Research has explored ways to enhance contraceptive counseling, focusing on increasing LARC use. Interventions that improve access, remove financial barriers, and enhance method-specific knowledge-especially regarding effectiveness-have led to higher LARC adoption and fewer unintended pregnancies and abortions. The COVID-19 pandemic significantly increased tele-health use for contraceptive counseling. Studies suggest tele-health expands appointment availability, reduces geographic barriers, and improves access to reproductive care, particularly in low-resource populations. However, few studies have examined tele-health's impact on contraceptive counseling, uptake, and satisfaction compared to in-person visits, particularly in Sweden. Before tele-health can be established as a viable family planning option, its counseling quality and impact on LARC adoption must be assessed. Study Aims: To determine whether the choice of LARC after tele-health (video) counseling is comparable to in-person counseling with a midwife, using structured contraceptive counseling in both groups. To assess whether LARC uptake three months post-counseling is similar between women who received tele-health vs. in-person counseling. This study will provide valuable insights into tele-health's role in contraceptive counseling and its potential to improve access to family planning services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2029
March 26, 2025
March 1, 2025
2.2 years
March 12, 2025
March 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in LARC use
Difference in proportion of women choosing LARC among participants receiving structured contraceptive counselling via telehealth (intervention) compared to in-person visit (control).
From enrollment to 12 months.
Study Arms (2)
Counselling through Telemedicine
EXPERIMENTALContraceptive counselling using LOWE methodology via telemedicine (video calls).
Contraceptive counselling via in-person visit
OTHERContraceptive counselling using the LOWE methodology via in-person visit.
Interventions
Contraceptive Counselling using the "LOWE Method" and through Tele Health, Video Call with Midwife.
Contraceptive Counselling using the "LOWE Method". In-person visit with midwife at Maternal Health Clinic.
Eligibility Criteria
You may qualify if:
- Women aged 16-40 years
- Primary reason for use of contraception being pregnancy prevention
- Not having pregnancy intentions within 6 months.
- Sufficient language skills to understand the study information available in Swedish and English.
You may not qualify if:
- Women in need for contraceptive method for medical reasons other than protection against unintended pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Örebro Countylead
- Örebro University, Swedencollaborator
- Karolinska Institutetcollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Brynhildsen, PhD
Örebro Universitet, Region Örebro
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2025
First Posted
March 26, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2029
Last Updated
March 26, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
According to Swedish law.